NPI | Name | Type | Address |
---|---|---|---|
DR. PHARMD Kelly Chillari |
Individual |
Unit 15246 Apo, AP |
|
DR. PHARMD Jordan Scott |
Individual |
665 Elm St Buffalo, NY |
|
PHARMD Nicole Lynn Zimmerman |
Individual |
2851 University Ave Green Bay, WI |
|
PHARMD Christina Michelle Lawson |
Individual |
1422 Big Horn Ave Sheridan, WY |
|
PHARMD Bryant Clemons |
Individual |
800 Rose St Lexington, KY |
|
DR. PHARMD Jianne Castelo De Raya |
Individual |
100 E Idaho St Boise, ID |
|
PHARMD Rachel Hamilton |
Individual |
100 E Idaho St Boise, ID |
|
PHARMD Daylan Storm |
Individual |
981090 Nebraska Medical Ctr Omaha, NE |
|
Janna Kaufman |
Individual |
4003 Kresge Way Ste 500 Louisville, KY |
|
Parwinder Purewal |
Individual |
3555 Round Barn Circle Santa Rosa, CA |
|
DR. PHARMD Adam Giron |
Individual |
601 E Rollins St Orlando, FL |
|
PHARMD Kallie Arthur White |
Individual |
1010 Bethesda Ct Winston Salem, NC |
|
DR. PHARMD Chihara O Talavera |
Individual |
3883 Airway Dr Santa Rosa, CA |
|
DR. PHARMD, BCPS Jill Cassaday |
Individual |
625 N 6th St Phoenix, AZ |
|
MS Laurel S Fields |
Individual |
18th Medcom Attn Dccs Qm Credentials Apo, AP |
|
PHARMD Christofer Kepinski |
Individual |
10030 Gilead Rd Ste 290 Huntersville, NC |
|
PHARMD Danielle Otto |
Individual |
University Of Kentucky 800 Rose St Lexington, KY |
|
DR. PHARM. D. Zane Matthias Waite |
Individual |
1 Guthrie Square Sayre, PA |
|
RPH, BCOP Paul Scott Hoffmann |
Individual |
1717 13th St Everett, WA |
|
PHARMD Angie Luong |
Individual |
16133 Ventura Blvd Encino, CA |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |